Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹228Prev. Close
₹222.5Turnover(Lac.)
₹40.94Day's High
₹228Day's Low
₹21852 Week's High
₹315.752 Week's Low
₹130Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
307.96P/E
27.77EPS
7.97Divi. Yield
07 Sep 2023
12:00 AM
Bonus
2 Aug 2023
12:00 AM
BookCloser
2 Aug 2023
12:00 AM
AGM
Announcement Date: 02 Aug, 2023
31 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 5.08 | 1.02 | 1.02 | 1.02 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 16.62 | 11.53 | 6.03 | 3.3 |
Net Worth | 21.7 | 12.55 | 7.05 | 4.32 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 135.66 | 114.22 | 99.12 | 70.53 | 38.84 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 135.66 | 114.22 | 99.12 | 70.53 | 38.84 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.54 | 1.35 | 0.93 | 0.62 | 0.57 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,521.8 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,558.95 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,479 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,099 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,459 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjaykumar Viththalbhai Patel
Executive Director
Pravin Bhadabhai Madhani
Executive Director
Mitesh Lavjibhai Chikhaliya
Independent Director
Keyur Shah
Independent Director
Tarun Ratilal Dobariya
Independent Director
Vaishakhi Ambrishbhai Shukla
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Infinium Pharmachem Ltd
Summary
Infinium Pharmachem Limited was originally incorporated as Infinium Pharmachem Private Limited on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted into Public Company and the name of Company was changed to Infinium Pharmachem Limited vide fresh Certificate of Incorporation dated August 12, 2022 by the RoC, Gujarat. Led by the Promoter, Sanjaykumar Viththalbhai Patel,in 2003, the Company established itself as a globally integrated & admired Pharmaceutical & Healthcare Company having manufacturing plant at Sojitra, Gujarat. The Company was incorporated with the objective of Manufacturing and supplying of Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It has penetrated the Pharmaceutical market with the CRAMS i.e. Contract Research & Manufacturing Services emphasizing on process optimization; developing / manufacturing the products specifically as per customers requirement and final application; customized packing / labelling; reliable supply of final product and focused to Iodine Chemistry.As of today, the Companys manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs.Later, in 2019, the Company formed a
Read More
What is the Infinium Pharmachem Ltd share price today?
The Infinium Pharmachem Ltd shares price on nse is Rs.₹221.3 today.
What is the Market Cap of Infinium Pharmachem Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Infinium Pharmachem Ltd is ₹307.96 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Infinium Pharmachem Ltd?
The PE and PB ratios of Infinium Pharmachem Ltd is 27.77 and 5.33 as of 03 Jul ‘24
What is the 52 Week High and Low of Infinium Pharmachem Ltd?
The 52-week high/low is the highest and lowest price at which a Infinium Pharmachem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Infinium Pharmachem Ltd is ₹130 and ₹315.7 as of 03 Jul ‘24
What is the CAGR of Infinium Pharmachem Ltd?
Infinium Pharmachem Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 63.90%, 6 Month at -1.11%, 3 Month at -2.31% and 1 Month at -0.63%.
What is the shareholding pattern of Infinium Pharmachem Ltd?
The shareholding pattern of Infinium Pharmachem Ltd is as follows:
Promoters - 73.05 %
Institutions - 0.00 %
Public - 26.95 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
